Variability in the susceptibility pattern of Bacteroides fragilis in four Detroit area hospitals.

Antimicrobial Agents and Chemotherapy
R E BawdonJ Krakowiak

Abstract

Recent clinical isolates of Bacteroides fragilis selected at random from four Detroit area hospitals were collected over a 3-month period, and the minimum inhibitory concentrations were determined within several days. The levels of antimicrobial agents used in this survey breached the concentration attainable in the patient's serum. The antimicrobial susceptibility patterns of these isolates to five antimicrobial agents suggest that there is a 20% variation in the resistance to clindamycin and also up to 20% variation among the other four antibiotics in the four area hospitals. The changing susceptibility pattern of B. fragilis to antibiotic resistance suggests that minimum inhibitory concentrations should be determined for all isolates from serious clinical infections.

References

Jul 13, 1978·Nature·J R Saunders
Oct 1, 1976·Antimicrobial Agents and Chemotherapy·V L Sutter, S M Finegold
Dec 1, 1976·Antimicrobial Agents and Chemotherapy·T D Wilkins, S Chalgren
Mar 1, 1976·Antimicrobial Agents and Chemotherapy·D J Blazevic
Jun 1, 1972·Antimicrobial Agents and Chemotherapy·T D WikinsW E Moore

❮ Previous
Next ❯

Citations

Apr 1, 1984·European Journal of Clinical Microbiology·M V BorobioE J Perea
Nov 1, 1986·Diagnostic Microbiology and Infectious Disease·T M FileL Tan
Mar 1, 1986·Diagnostic Microbiology and Infectious Disease·H M WexlerS M Finegold
Jun 1, 1997·Journal of Clinical Periodontology·N PaciniA Ferrari
Oct 1, 1976·Antimicrobial Agents and Chemotherapy·T A KurzynskiC R Field
Apr 1, 1980·Antimicrobial Agents and Chemotherapy·W J Brown, P E Waatti
Nov 1, 1981·Antimicrobial Agents and Chemotherapy·R D Rolfe, S M Finegold
Nov 1, 1982·Antimicrobial Agents and Chemotherapy·A SosaS L Gorbach
May 1, 1983·Antimicrobial Agents and Chemotherapy·P K MarshF P Tally
Jun 1, 1983·Antimicrobial Agents and Chemotherapy·F A Zar
Oct 1, 1984·Antimicrobial Agents and Chemotherapy·A G HelstadT A Kurzynski
Nov 1, 1986·Antimicrobial Agents and Chemotherapy·A M BourgaultF Lamothe
Apr 1, 1990·Antimicrobial Agents and Chemotherapy·C BetriuJ J Picazo
Feb 1, 1985·Antimicrobial Agents and Chemotherapy·E J Goldstein, D M Citron
Nov 1, 1982·The American Journal of Medicine
Oct 1, 1983·Journal of Clinical Microbiology·P R Murray, C J Weber
Sep 1, 1982·Antimicrobial Agents and Chemotherapy·J P O'KeefeK D Thompson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.